NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Valcare Medical

Valcare Medical

Private
Wilmington, DelawareHealthcare & Life Scienceshttps://www.valcaremedical.com/

Last Round

Series B

Sep 1, 2018

Total Funding Raised

$34M

Company Overview

Valcare Medical is a therapeutic devices company that develops minimally invasive transcatheter solutions for mitral and tricuspid regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter mitral valve repairTMVrannuloplasty ringstructural hearttranscatheter annuloplastymitral regurgitation treatmentinterventional cardiologyvalve repair deviceMedTechminimally invasive devicetricuspid regurgitation treatmentclinical-stage medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valcare Medical Comparables

Compare Valcare Medical with similar companies based on industry and business-model similarity.

Valcare Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AVVie GmbH
88%
Micro Interventional Devices, Inc.
88%
MEACOR
87%

Valcare Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 1, 2018
Series AJul 11, 2012

Key People

Founding team and executive leadership

Steve Sandweg

Chief Executive Officer

Executive Team

Nadav Yellin

General Manager and COO

Executive Team

Valcare Medical Investors

Notable investors and investment history

Valcare Medical investors
InvestorRounds
AccelmedSeries A
Arkin CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors increased 78% MoM.

  • Feb 23, 2025

    Monthly visitors increased 73% MoM.

Valcare Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valcare Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valcare Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWilmington, Delaware
Employee Range36
Year Founded2012
Last FundingSep 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.